ES2950560T3 - Agonistas del receptor CXCR3 - Google Patents
Agonistas del receptor CXCR3 Download PDFInfo
- Publication number
- ES2950560T3 ES2950560T3 ES17765033T ES17765033T ES2950560T3 ES 2950560 T3 ES2950560 T3 ES 2950560T3 ES 17765033 T ES17765033 T ES 17765033T ES 17765033 T ES17765033 T ES 17765033T ES 2950560 T3 ES2950560 T3 ES 2950560T3
- Authority
- ES
- Spain
- Prior art keywords
- mmol
- compound
- dcm
- pharmaceutically acceptable
- isotope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662383202P | 2016-09-02 | 2016-09-02 | |
| US201762478496P | 2017-03-29 | 2017-03-29 | |
| PCT/US2017/049768 WO2018045246A1 (en) | 2016-09-02 | 2017-08-31 | Cxcr3 receptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2950560T3 true ES2950560T3 (es) | 2023-10-11 |
Family
ID=59846729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17765033T Active ES2950560T3 (es) | 2016-09-02 | 2017-08-31 | Agonistas del receptor CXCR3 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20190345133A1 (OSRAM) |
| EP (1) | EP3507275B1 (OSRAM) |
| JP (1) | JP7181857B2 (OSRAM) |
| AU (1) | AU2017318674B2 (OSRAM) |
| CA (1) | CA3034108A1 (OSRAM) |
| ES (1) | ES2950560T3 (OSRAM) |
| MX (1) | MX380217B (OSRAM) |
| WO (1) | WO2018045246A1 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021163272A2 (en) | 2020-02-12 | 2021-08-19 | The Regents Of The University Of California | Platelet factors and cognitive improvement |
| CN111943823A (zh) * | 2020-09-16 | 2020-11-17 | 安徽工业大学 | 一种苯菌酮的制备方法 |
| CN116178383B (zh) * | 2022-12-26 | 2025-04-22 | 南方科技大学 | 生物碱及三价铁卟啉催化合成生物碱的方法 |
-
2017
- 2017-08-31 AU AU2017318674A patent/AU2017318674B2/en not_active Ceased
- 2017-08-31 MX MX2019002166A patent/MX380217B/es unknown
- 2017-08-31 WO PCT/US2017/049768 patent/WO2018045246A1/en not_active Ceased
- 2017-08-31 ES ES17765033T patent/ES2950560T3/es active Active
- 2017-08-31 CA CA3034108A patent/CA3034108A1/en not_active Abandoned
- 2017-08-31 EP EP17765033.0A patent/EP3507275B1/en active Active
- 2017-08-31 US US16/335,641 patent/US20190345133A1/en not_active Abandoned
- 2017-08-31 JP JP2019512307A patent/JP7181857B2/ja active Active
-
2020
- 2020-05-11 US US16/872,161 patent/US11040954B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3034108A1 (en) | 2018-03-08 |
| US11040954B1 (en) | 2021-06-22 |
| MX380217B (es) | 2025-03-12 |
| AU2017318674B2 (en) | 2020-11-12 |
| EP3507275A1 (en) | 2019-07-10 |
| AU2017318674A1 (en) | 2019-03-28 |
| JP7181857B2 (ja) | 2022-12-01 |
| EP3507275B1 (en) | 2023-04-26 |
| MX2019002166A (es) | 2019-06-12 |
| US20190345133A1 (en) | 2019-11-14 |
| JP2019533639A (ja) | 2019-11-21 |
| WO2018045246A1 (en) | 2018-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018272359B2 (en) | Lactam compound as FXR receptor agonist | |
| TWI789381B (zh) | 雜環化合物 | |
| CN108774214B (zh) | 作为激酶抑制剂的杂环酰胺 | |
| ES2699905T3 (es) | Aril dihidropiridinonas y piperidinonas como inhibidores de MGAT2 | |
| ES2864349T3 (es) | Nuevos moduladores del receptor GLP-1 | |
| BR112020011779A2 (pt) | derivados de sulfonil ureia como moduladores de inflamassona nlrp3 | |
| ES2606685T3 (es) | Moduladores de dihidropirazol GPR40 | |
| AU2016242973A1 (en) | Inhibitors of indoleamine 2,3-dioxygenase for the treatment of cancer | |
| WO2012009258A2 (en) | Peptidomimetic galanin receptor modulators | |
| ES2719713T3 (es) | Inhibidores de MGAT2 de dihidropiridinona sustituidos con tetrazolona | |
| EP2234487A1 (en) | Anilides and analogs as rho kinase inhibitors | |
| JP2007516298A (ja) | 新規なスピロインドリンまたはスピロイソキノリン化合物、それらの使用方法および組成物 | |
| JP2025505882A (ja) | Pargの阻害物質 | |
| ES2700574T3 (es) | Inhibidores de MGAT2 dihidropiridinona para su uso en el tratamiento de trastornos metabólicos | |
| ES2950560T3 (es) | Agonistas del receptor CXCR3 | |
| CN101817767A (zh) | 取代磺酰胺类化合物及其制备方法、药物组合物和应用 | |
| CA2709879A1 (en) | Anilides and analogs as rho kinase inhibitors | |
| WO2015171757A1 (en) | Pyrrolidine gpr40 modulators | |
| TWI537251B (zh) | Fpr1拮抗劑的衍生物及其用途 | |
| EP4301746A1 (en) | Diazepine derivatives useful in the treatment of clostridium difficile | |
| RU2776052C2 (ru) | Лактамное соединение в качестве агониста рецептора FXR | |
| CN106061953A (zh) | 结合至pparg但不用作启动子的化合物和用于治疗与pparg相关的疾病的包含所述化合物作为活性成分的药物学组合物 | |
| JPWO2014021383A1 (ja) | 縮環複素環化合物 | |
| Jain et al. | Synthesis, characterization and In-silico study of some 4-nitro-N-(piperidin-4-yl) benzamide derivatives as GPR119 agonists for the treatment of diabetes | |
| CA3262137A1 (en) | Spiro compound and application thereof |